- Home
- KIND vs KLTOW Comparison
KIND vs KLTOW Comparison
Compare KIND & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- KLTOW
- Stock Information
- Founded
- KIND 2011
- KLTOW N/A
- Country
- KIND United States
- KLTOW United States
- Employees
- KIND N/A
- KLTOW 3
- Industry
- KIND Computer Software: Programming Data Processing
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KIND Technology
- KLTOW Health Care
- Exchange
- KIND Nasdaq
- KLTOW Nasdaq
- Market Cap
- KIND 608.3M
- KLTOW N/A
- IPO Year
- KIND N/A
- KLTOW 2022
- Fundamental
- Price
- KIND $1.60
- KLTOW $0.25
- Analyst Decision
- KIND Buy
- KLTOW
- Analyst Count
- KIND 4
- KLTOW 0
- Target Price
- KIND $2.56
- KLTOW N/A
- AVG Volume (30 Days)
- KIND 2.1M
- KLTOW N/A
- Earning Date
- KIND 08-06-2025
- KLTOW N/A
- Dividend Yield
- KIND N/A
- KLTOW N/A
- EPS Growth
- KIND N/A
- KLTOW N/A
- EPS
- KIND N/A
- KLTOW N/A
- Revenue
- KIND $248,306,000.00
- KLTOW N/A
- Revenue This Year
- KIND $1.77
- KLTOW N/A
- Revenue Next Year
- KIND $10.72
- KLTOW N/A
- P/E Ratio
- KIND N/A
- KLTOW N/A
- Revenue Growth
- KIND 12.01
- KLTOW N/A
- 52 Week Low
- KIND $1.32
- KLTOW N/A
- 52 Week High
- KIND $3.00
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- KIND 52.63
- KLTOW N/A
- Support Level
- KIND $1.55
- KLTOW N/A
- Resistance Level
- KIND $1.66
- KLTOW N/A
- Average True Range (ATR)
- KIND 0.07
- KLTOW 0.00
- MACD
- KIND -0.00
- KLTOW 0.00
- Stochastic Oscillator
- KIND 53.13
- KLTOW 0.00
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.